Grupo de Investigación en Cáncer de Mama
NEONCOBREAST
Massachusetts General Hospital
Boston, Estados UnidosPublications in collaboration with researchers from Massachusetts General Hospital (1)
2013
-
A dominant-negative N-terminal fragment of HER2 frequently expressed in breast cancers
Oncogene, Vol. 32, Núm. 11, pp. 1452-1459